MedPath

Evaluation of Fusion After ALIF With an Osteoinductive Material or With Homologus Bone

Not Applicable
Completed
Conditions
Fusion of Spine, Lumbar Region
Interventions
Device: Homologous Bone
Device: NanoBone
Registration Number
NCT03331159
Lead Sponsor
Johann Wolfgang Goethe University Hospital
Brief Summary

The aim of this study was to determine whether instrumented anterior lumbar interbody Fusion with a new nanocrystalline hydroxyapatite embedded in a silica gel matrix (NH-SiO2) was associated with superior radiological and clinical outcomes at 12 months follow-up compared with instrumented ALIF with homologous bone

Detailed Description

This randomized clinical trial included two groups of 20 mature patients with mono- or multisegmental degenerative disease of the lumbar spine who were suitable to undergo mono- or bisegmental ALIF fusion at the level L4/L5 and L5/S1 with a carbon fiber reinforced polymer ALIF cage filled with either NH-SiO2 or homologous bone (HB). Patients were followed 12 months postoperatively. The primary aim was to compare postoperative disability as measured by the Oswestry Disability Index (ODI). Secondary aims were to compare postoperative radiographic outcomes and differences in pain and quality of life between these groups.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • chronic low back pain
  • sensorimotor deficits
  • radiculopathy and spinal claudication symptoms, all caused by degenerative changes in the lumbar spine, which were resistant to conservative pain therapy and / or physiotherapy
Exclusion Criteria
  • previous surgeries in the abdominal Region
  • previous fusion surgery in the lumbar spine.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Homologous boneHomologous BoneThe participants were treated with anterior lumbar interbody fusion (ALIF) with homologous bone
NanoBoneNanoBoneThe participants were treated with anterior lumbar interbody fusion (ALIF) with a new nanocrystalline hydroxyapatite embedded in a silica gel matrix (NH-SiO2)
Primary Outcome Measures
NameTimeMethod
Oswestry Disability Index (ODI)12 months after surgery

Postoperative disability as measured by the Oswestry Disability Index (ODI)

Secondary Outcome Measures
NameTimeMethod
Fusion rate12 months after surgery

Postoperative radiographic Fusion rate

© Copyright 2025. All Rights Reserved by MedPath